Department of Neurology, University of Duisburg-Essen, Essen, Germany.
Int J Stroke. 2013 Oct;8(7):503-9. doi: 10.1111/j.1747-4949.2011.00752.x. Epub 2012 Feb 20.
In-patient rehabilitation following ischemic stroke offers a unique opportunity for risk factor and lifestyle modification. Quantification of risk in this setting may help to tailor therapy, increase physician awareness and patient compliance and thus to reduce recurrent vascular events.
To validate the predictive value of established secondary stroke risk scores.
One thousand one hundred sixty-three patients undergoing in-patient rehabilitation following recent ischemic stroke in 15 German neurologic rehabilitation centers were included 0·9 ± 0·5 months after the index event. Outcome information was available for 846 participants (72·7%) after a mean follow-up of 13 ± 2·3 months.
Patients' mean age was 66·3 ± 12·3 years and 42·5% were women. The National Institutes of Health Stroke Scale (mean 4·0 ± 3·9), modified Rankin scale (median 2, range 0-5), and Barthel Index (median 90, range 0-100) indicated good functional status. A recurrent fatal or nonfatal stroke during follow-up occurred in 6·7% and combined vascular events (stroke, myocardial infarction, vascular death) in 10·9%. The predictive accuracy for recurrent stroke was slightly higher on the Essen Stroke Risk Score than on the Stroke Prognostis Instrument II (area under the curve 0·62 vs. 0·56), while both scores had a similar predictive accuracy for combined vascular events.
Risk stratification on the Essen Stroke Risk Score and Stroke Prognostis Instrument II provides a moderate accuracy for the prediction of recurrent stroke and vascular events in patients undergoing neurologic in-patient rehabilitation. Although individual risk prediction may remain imprecise, the use of these scores should be encouraged.
缺血性脑卒中后的住院康复为调整风险因素和生活方式提供了独特的机会。在这种情况下量化风险有助于定制治疗方案,提高医生的意识和患者的依从性,从而降低复发性血管事件的发生。
验证已建立的二级卒中风险评分的预测价值。
1163 例在德国 15 个神经康复中心接受近期缺血性脑卒中住院康复的患者在指数事件后 0.9±0.5 个月入组。在平均 13±2.3 个月的随访后,有 846 名参与者(72.7%)获得了结果信息。
患者的平均年龄为 66.3±12.3 岁,42.5%为女性。美国国立卫生研究院卒中量表(平均 4.0±3.9)、改良 Rankin 量表(中位数 2,范围 0-5)和巴氏指数(中位数 90,范围 0-100)表明功能状态良好。在随访期间,6.7%的患者发生致命或非致命性复发性卒中,10.9%的患者发生联合血管事件(卒中、心肌梗死、血管性死亡)。Essen 卒中风险评分预测复发性卒中的准确性略高于卒中预后仪器 II(曲线下面积 0.62 比 0.56),而这两个评分对联合血管事件的预测准确性相似。
Essen 卒中风险评分和卒中预后仪器 II 的风险分层对接受神经科住院康复治疗的患者复发性卒中及血管事件的预测具有中等准确性。尽管个体风险预测可能仍然不精确,但应鼓励使用这些评分。